Published in Medicine and Law Weekly, March 25th, 2005
EntreMed scientists presented posters on three of its oncology programs including:
1) Panzem NCD (2-methoxyestradiol or 2ME2), the company's lead product candidate, which is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly